| Date | Event | Description |
|---|---|---|
| 6 May 2008 | Amended | Converted to new review format. |
| 24 January 2008 | Amended | On November 2007 the UK Medicines and Healthcare Regulatory Authority suspended the marketing authorisation for Lumiracoxib following safety concerns relating to liver damage in patients prescribed the drug for chronic/long term condiions such as osteoarthritis |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.